Optimising Diagnostics For Precision Medicine

Transforming diagnostic standards and drug development for
Nonalcoholic Steatohepatitis (NASH) with AI-based digital pathology

Who We Are

Founder of an AI-based digital pathology solution that
aids NASH clinical trials towards optimal outcomes

Bridging Research and Drug Discovery

Working hand-in-hand with our collaborators to accelerate clinical research
and drug development efforts with unrivalled accuracy and sensitivity

NASH Highlights

Catch up on the latest medical advancements and research discoveries on Nonalcoholic Steatohepatitis (NASH) taking place across the globe.

About Us

We are committed towards enhancing the diagnosis of chronic liver conditions like nonalcoholic steatohepatitis (NASH), and accelerating the development of effective treatments.

Find Out More

Game-Changing Solutions

Revolutionizing tissue assessment with Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) to provide quantitative, objective and accurate data.

Find Out More
Website qFibrosis and qFIBS duo border


Find Out More

Our Achievements

We have been recognised with several industry-renowned awards for our efforts and accomplishments in the core areas of our business, particularly medical technology and product innovation.

Web banner Histoindex 2

Find Out More


Keep in touch with our upcoming and past events!

Find Out More

Talk To Us

Our team will be happy to answer your queries

Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept